semaglutide fda approval weight loss The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for loss, Novo Nordisk announced on Monday. The once-daily 25 FDA Approves Oral Semaglutide as

Key Takeaways Different FDA Approvals : Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30) or weight-related conditions (BMI 27), while Ozempic is FDA-approved only for type 2 diabetes management

Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases

Mounjaro may be more effective than Trulicity for weight loss based on clinical trials

So, if youre thinking about giving this a shot, take it slow, listen to your body, and keep your doctor in the loop

Its hallmark features are an acute unilateral painless onset of visual impairment, relative afferent pupillary defect (RAPD) and hyperemic optic disc swelling